Alpha Teknova TKNO Stock
Alpha Teknova Price Chart
Alpha Teknova TKNO Financial and Trading Overview
| Alpha Teknova stock price | 5.13 USD |
| Previous Close | 5.4 USD |
| Open | 5.44 USD |
| Bid | 4.09 USD x 200 |
| Ask | 6.56 USD x 200 |
| Day's Range | 5.12 - 5.78 USD |
| 52 Week Range | 1.91 - 6.68 USD |
| Volume | 420.3K USD |
| Avg. Volume | 126.5K USD |
| Market Cap | 287.91M USD |
| Beta (5Y Monthly) | 0.473 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.31 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 9 USD |
TKNO Valuation Measures
| Enterprise Value | 299.56M USD |
| Trailing P/E | N/A |
| Forward P/E | -21.918367 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 6.8874054 |
| Price/Book (mrq) | 4.182243 |
| Enterprise Value/Revenue | 7.166 |
| Enterprise Value/EBITDA | -31.626 |
Trading Information
Alpha Teknova Stock Price History
| Beta (5Y Monthly) | 0.473 |
| 52-Week Change | -5.75% |
| S&P500 52-Week Change | 27.69% |
| 52 Week High | 6.68 USD |
| 52 Week Low | 1.91 USD |
| 50-Day Moving Average | 3.35 USD |
| 200-Day Moving Average | 3.92 USD |
TKNO Share Statistics
| Avg. Volume (3 month) | 126.5K USD |
| Avg. Daily Volume (10-Days) | 159.06K USD |
| Shares Outstanding | 53.61M |
| Float | 10.88M |
| Short Ratio | 12.47 |
| % Held by Insiders | 9.32% |
| % Held by Institutions | 84.72% |
| Shares Short | 1.27M |
| Short % of Float | 11.61% |
| Short % of Shares Outstanding | 2.36% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -41.071% |
| Operating Margin (ttm) | -38.80% |
| Gross Margin | 34.01% |
| EBITDA Margin | -22.65% |
Management Effectiveness
| Return on Assets (ttm) | -9.29% |
| Return on Equity (ttm) | -23.92% |
Income Statement
| Revenue (ttm) | 41.8M USD |
| Revenue Per Share (ttm) | 0.78 USD |
| Quarterly Revenue Growth (yoy) | 13.10% |
| Gross Profit (ttm) | 14.22M USD |
| EBITDA | -9472000 USD |
| Net Income Avi to Common (ttm) | -17169000 USD |
| Diluted EPS (ttm) | -0.31 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 17.78M USD |
| Total Cash Per Share (mrq) | 0.33 USD |
| Total Debt (mrq) | 27.83M USD |
| Total Debt/Equity (mrq) | 42.86 USD |
| Current Ratio (mrq) | 4.593 |
| Book Value Per Share (mrq) | 1.284 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -7902000 USD |
| Levered Free Cash Flow (ttm) | -2387875 USD |
Profile of Alpha Teknova
| Country | United States |
| State | CA |
| City | Hollister |
| Address | 2451 Bert Dr. |
| ZIP | 95023 |
| Phone | 831 637 1100 |
| Website | https://www.teknova.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 158 |
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.
Q&A For Alpha Teknova Stock
What is a current TKNO stock price?
Alpha Teknova TKNO stock price today per share is 5.13 USD.
How to purchase Alpha Teknova stock?
You can buy TKNO shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Alpha Teknova?
The stock symbol or ticker of Alpha Teknova is TKNO.
Which industry does the Alpha Teknova company belong to?
The Alpha Teknova industry is Drug Manufacturers - Specialty & Generic.
How many shares does Alpha Teknova have in circulation?
The max supply of Alpha Teknova shares is 53.61M.
What is Alpha Teknova Price to Earnings Ratio (PE Ratio)?
Alpha Teknova PE Ratio is now.
What was Alpha Teknova earnings per share over the trailing 12 months (TTM)?
Alpha Teknova EPS is -0.31 USD over the trailing 12 months.
Which sector does the Alpha Teknova company belong to?
The Alpha Teknova sector is Healthcare.
Alpha Teknova TKNO included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
| Stlmt ID US Tech Biotechnology NBX | 3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
| US Tech Global Market Composite NQGM | 2296 USD — |
-1.38
|
— — | 2280.64 USD — | 2323.09 USD — | — - | — — |
| US Tech Biotechnology NBI | 5807.22 USD — |
+1.87
|
— — | 5685.34 USD — | 5809.82 USD — | — - | — — |
| US Tech Health Care IXHC | 1133.51 USD — |
+1.54
|
— — | 1113.35 USD — | 1133.95 USD — | — - | — — |
- {{ link.label }} {{link}}